JPRN-UMIN000004427已完成2 期
A Prospective Randomized Open Trial to Assess the Efficiency of Infliximab for Crohn's Patients after Intestinal Resection - Infliximab for Crohn's Disease Patients after Intestinal Resection
ower GI disease, Hyogo College of Medicine0 个研究点目标入组 30 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.A patient who has had hypersensitivity to infliximab. 2.A patient who has had a surgery for anal lesion (without intestinal resection) as a reason to be involved for this trial. 3.A patient who has abscess lesion(s). 4.A patient who has past and/or present episode of tuberoses infection. 5.A patient who is determined as ineligible for a subject in this study by a doctor in charge or others.
研究者
相似试验
进行中（未招募）
不适用
Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH (Fostipur®, IBSA) versus Recombinant FSH (Bemfola® Finox) in Oocyte Donors Undergoing Controlled Ovarian Stimulation Based on Receptor N680S FSH Gene PolymorphismEUCTR2015-003779-31-ESINSTITUTO BERNABE
尚未招募
2 期
The Nitazoxanide Plus Atazanavir for COVID-19 StudyPACTR202008855701534Obafemi Awolowo University98
招募中
2 期
Management of Lymphatic Filariasis with Homeopathic Medicines.CTRI/2011/12/002268Central Council for Research in Homoeopathy112
进行中（未招募）
1 期
Study to reduce the risk of growth or rupture of a localized dilatation of a blood vessel inside the head by managing risk factorsSaccular cerebral aneurysmMedDRA version: 20.1Level: PTClassification code 10022758Term: Intracranial aneurysmSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-000514-35-NLRuprecht-Karls-University Heidelberg, Medical Faculty Mannheim776
招募中
3 期
Prospective Randomised Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U)NL-OMON52612Ruprecht-Karls-University Heidelberg, Medical Faculty Mannheim355